• Home
  • Archives
  • Contact
Thu, February 25, 2021

Venable Fitzpatrick's Legal Updates / Medical Devices

Legal Updates/
Medical Devices

SORT BY:
OR
Home Type IPR Petitions

Recent Posts

IPR Petitions, IPRs Filed, USPTO/PTAB

Petition for Inter Partes Review by Alphatec Holdings

On December 13, 2018, Alphatec Holdings, Inc. (“Petitioner”) filed a Petition to the USPTO’s Patent Trial and Appeal Board (“Board”)…

December 13, 2018
IPRs Filed, USPTO/PTAB

Petitions for Inter Partes Review by Cardiovascular Systems

On December 7, 2018, Cardiovascular Systems, Inc. (“Petitioners”) filed three Petitions to the USPTO’s Patent Trial and Appeal Board (“Board”)….

December 7, 2018
IPRs Filed, USPTO/PTAB

Cardiovascular Systems Files Petition for IPR Against Cardio Flow’s Atherectomy Device Patent

September 6, 2018 – On September 5, 2018, Cardiovascular Systems, Inc. filed a petition for inter partes review against Cardio…

September 6, 2018
IPRs Filed, USPTO/PTAB

Edge Endo Files Multiple IPR Petitions Against Scianamblo’s Endodontic Instrument Patents

July 2, 2018 – On June 29, 2018, Bobby Bennett, Charles Goodis, Edge Endo, LLC, Edge Holdings, LLC, Guidance Endodontics,…

July 2, 2018
IPRs Filed, USPTO/PTAB

Natera Files Petition for IPR Against Illumina’s Fetal Abnormality Detection Patent

July 2, 2018 – On June 29, 2018, Natera, Inc. filed a petition for inter partes review against Illumina’s fetal…

July 2, 2018
IPRs Filed, USPTO/PTAB

Apple Inc. petitions for IPR of Valencell, Inc.’s “Physiological monitoring methods and apparatus” patent

March 7, 2018—Valencell, Inc. owns US 9,289,135, directed to a method of photoplethysmography (PPG), an optical technique whereby light is…

March 7, 2018
IPRs Filed, USPTO/PTAB

Waters Technologies Files IPR Against Biomedical Device Consultants & Laboratories Related to Testing System For Evaluating Heart Valves

January 16, 2018 – Waters Technologies Corp. filed a petition for inter partes review against Patent Owner Biomedical Device Consultants…

January 16, 2018
IPRs Filed, USPTO/PTAB

Synaptive Medical Inc. requests an Inter Partes Review of Karl Storz Endoscopy-America, Inc.’s endoscopic camera patent

January 12, 2018 ­– Synaptive Medical Inc. filed a petition for inter partes review of Claims 1-19 of Patent No….

January 12, 2018
IPRs Filed, USPTO/PTAB

10X Genomics Files Three Inter Partes Review Petitions Against Bio-Rad Laboratories

January 10, 2018 – 10X Genomics, Inc. filed three inter partes review petitions to invalidate one of Bio-Rad Laboratories, Inc.’s…

January 10, 2018
IPRs Filed, USPTO/PTAB Decisions

Petition for Inter Partes Review by Orthopediatrics Corp.

On January 8, 2018, Iridex Corporation (“Plaintiff”) filed a complaint against Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A….

January 8, 2018
Load More

Popular Posts

  • IPR / PGR / CBM Medical Device Updates in November 2020
  • IPR / PGR / CBM Medical Device Updates in October 2020
  • IPR / PGR / CBM Medical Device Updates in September 2020
  • IPR / PGR / CBM Medical Device Updates in August 2020
  • IPR / PGR / CBM Medical Device Updates in July 2020

Connect With Us

ATTORNEY ADVERTISING

® /TM / © Venable LLP 2020. All Rights Reserved.

The individuals who maintain this site work for Venable LLP. The information, comments and links posted on this site do not constitute legal advice. No attorney-client relationship has been or will be formed by any communication(s) to, from or with the site and/or the author. For legal advice, contact an attorney at Venable LLP or an attorney actively practicing in your jurisdiction. Do not send any confidential or privileged information to the author; neither Venable LLP nor the author will assume any liability or responsibility for it. If you send any information, documents or materials to the site, you give permission for the author to include them on or in the site. No information, documents or materials you send to the site will be considered confidential or privileged by Venable LLP or its lawyers. Also, no such information, documents or materials will be returned to you. All decisions relating to the content belong to the author.